Degree in Computational Biology
Biostatistics, Data science techniques, Linux Operating system, Python Programming, R Programming, Unix Operating system
Do you have expertise in the analysis and interpretation of multi-omic data from complex immunopathologies? Would you like to apply your expertise to the development of new immuno-oncology therapies in a company that follows the science and turns ideas into life-changing medicines? Then AstraZeneca’s Early Oncology Data Science team might be the place for you!
About AstraZeneca
At AstraZeneca, we put patients first and strive to meet their unmet needs worldwide. Working here means being entrepreneurial, thinking big and working together to make the impossible a reality. If you are swift to action, confident to lead, willing to collaborate, and curious about what science can do, then you’re our kind of person.
Early Oncology Data Science
The vision of AstraZeneca Oncology is to redefine cancer, redefine our solutions to cancer, and restore patients' lives. The Early Oncology Data Science team is an integral part of Oncology Drug Discovery at AstraZeneca, working throughout the research and early development pipeline from new target discovery to translational medicine and clinical trials. Our global group aligns its data science expertise to AstraZeneca’s primary areas of focus in Oncology: Immuno-Oncology, Cell Therapies, DNA Damage and Response, Tumour Drivers & Resistance, Epigenetics, and Antibody-Drug Conjugates.
What you’ll do
You will work in cross-functional teams where you will apply your knowledge of data science methods, capabilities and public or proprietary pre-clinical and clinical studies to produce data-driven actionable insights that accelerate the discovery and development of cell therapies and the next generation of molecules that modify the tumour immune environment.
Responsibilities:
Education, Qualifications, Skills and Experience
Essential for the role:
Desirable for the role:
AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. It has been involved in developing the Oxford-AstraZeneca COVID-19 vaccine.
Gaithersburg, MD, USA
2-4 year
South San Francisco, CA, USA
2-4 year
Wilmington, DE, USA
2-4 year
Cambridge, UK
2-4 year
Macclesfield, UK
2-4 year
Waltham, MA, USA
2-4 year
Gothenburg, Sweden
0-2 year
Warsaw, Poland
0-2 year
Waltham, MA, USA
4-6 year
Macclesfield, UK
2-4 year
Gaithersburg, MD, USA
2-4 year
Waltham, MA, USA
2-4 year
Barcelona, Catalonia, Spain
4-6 year
Barcelona, Catalonia, Spain
4-6 year
Barcelona, Catalonia, Spain
4-6 year
Waltham, MA, USA
2-4 year
Gaithersburg, MD, USA
2-4 year
Cambridge, UK
0-2 year